CAS 38666-30-7

Imidazo[1,5-a]pyridine, 5,6,7,8-tetrahydro- (9CI)

Description:

Imidazo[1,5-a]pyridine, 5,6,7,8-tetrahydro- is a bicyclic organic compound characterized by its fused imidazole and pyridine rings. This compound features a saturated tetrahydro structure, which contributes to its unique chemical properties. It is typically a colorless to pale yellow solid and is soluble in various organic solvents. The presence of nitrogen atoms in its structure imparts basicity and potential reactivity, making it of interest in medicinal chemistry and drug development. The compound may exhibit biological activity, including antimicrobial or anticancer properties, due to its structural similarity to other biologically active heterocycles. Its CAS number, 38666-30-7, is a unique identifier that facilitates its identification in chemical databases. As with many nitrogen-containing heterocycles, it may participate in various chemical reactions, including electrophilic substitutions and nucleophilic attacks, making it a versatile building block in organic synthesis. Safety data should be consulted for handling and usage, as with any chemical substance.

Synonyms:

• Imidazo[1,5-a]pyridine, 5,6,7,8-tetrahydro-
• 5,6,7,8-Tetrahydroimidazo[1,5-a]pyridine

Imidazo[1,5-a]pyridine, 5,6,7,8-tetrahydro- (9CI)

CAS: 38666-30-7

Formula: C₇H₁₀N₂

Purity: 96%

Color and Shape: Solid

Molecular weight: 122.1677

Ref: IN-DA00BYK7

5,6,7,8-Tetrahydroimidazo[1,5-a]pyridine

CAS: 38666-30-7

5,6,7,8-Tetrahydroimidazo[1,5-a]pyridine

Purity: 96%

Molecular weight: 122.17g/mol

Ref: 54-OR83978

5,6,7,8-Tetrahydroimidazo[1,5-a]pyridine

CAS: 38666-30-7

Purity: 96%

Molecular weight: 122.1709976

Ref: 10-F621772

5H,6H,7H,8H-Imidazo[1,5-a]pyridine

CAS: 38666-30-7

Imidazo[1,5-a]pyridine is a medicament that is used to treat pediatric patients and humans. It has been shown to be effective in the treatment of hyperaldosteronism and has a low risk of side effects. Imidazo[1,5-a]pyridine inhibits the enzymes farnesyltransferase and geranylgeranyltransferase I, which are involved in cholesterol biosynthesis. This inhibition leads to lower levels of cholesterol and other sterols. The drug also has an intramolecular ring system that stabilizes its conformation. A phosphate salt form of imidazo[1,5-a]pyridine is available for oral administration.

Formula: C₇H₁₀N₂

Purity: Min. 95%

Molecular weight: 122.17 g/mol

Ref: 3D-NBA66630